Archives parkinsons

by in
Entry Author Date Location
Denali Rises With $217M and Genentech Alumni to Fight Brain Diseases 05/14/15 San Francisco
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Seven Takeaways From “What’s Hot in Boston Biotech” 04/10/15 Boston
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
Steven Paul, Former Lilly R&D Chief, Takes Head Seat at Voyager 09/03/14 Boston
East Coast Biotech Roundup: LTI, SolveBio, Proteon, & More 05/16/14 Boston
LTI Corrals $5M to Exploit Link Between Gaucher, Parkinson’s 05/12/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Neurophage Nabs $17M More to Hunt Down Brain Plaques 03/25/14 Boston
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Hunting For Brain Plaques, Neurophage Turns to a Virus 01/31/14 Boston
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
Proteostasis, Biogen Team up on Protein Homeostasis Drugs 12/09/13 Boston
The Greater Seattle Brain Science Cluster 03/16/12 Seattle
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs 05/25/11 Boston
Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting 04/14/11 Seattle
Who’s Going to Pay for Future Drug Development? (Part 1) 03/22/11 National
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders 03/01/11 Boston
Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News 01/14/11 Boston
iPierian Nabs $28M, With New Backing From Glaxo and Biogen Idec, To Use Stem Cells for Drug Discovery 09/08/10 San Francisco
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News 05/07/10 Boston
Proteostasis, with San Diego Roots and Boston Home, Seeks Edge in Alzheimer’s and Parkinson’s 05/03/10 Boston
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood 01/19/10 Boston
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key 10/18/09 National
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day 10/08/09 Seattle
Page 1 of 2 next page »